Correlation Between Smartgiant Technology and Cabio Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Smartgiant Technology and Cabio Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smartgiant Technology and Cabio Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smartgiant Technology Co and Cabio Biotech Wuhan, you can compare the effects of market volatilities on Smartgiant Technology and Cabio Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smartgiant Technology with a short position of Cabio Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smartgiant Technology and Cabio Biotech.

Diversification Opportunities for Smartgiant Technology and Cabio Biotech

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Smartgiant and Cabio is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Smartgiant Technology Co and Cabio Biotech Wuhan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cabio Biotech Wuhan and Smartgiant Technology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smartgiant Technology Co are associated (or correlated) with Cabio Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cabio Biotech Wuhan has no effect on the direction of Smartgiant Technology i.e., Smartgiant Technology and Cabio Biotech go up and down completely randomly.

Pair Corralation between Smartgiant Technology and Cabio Biotech

Assuming the 90 days trading horizon Smartgiant Technology Co is expected to generate 1.22 times more return on investment than Cabio Biotech. However, Smartgiant Technology is 1.22 times more volatile than Cabio Biotech Wuhan. It trades about -0.01 of its potential returns per unit of risk. Cabio Biotech Wuhan is currently generating about -0.01 per unit of risk. If you would invest  4,068  in Smartgiant Technology Co on October 23, 2024 and sell it today you would lose (59.00) from holding Smartgiant Technology Co or give up 1.45% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy95.24%
ValuesDaily Returns

Smartgiant Technology Co  vs.  Cabio Biotech Wuhan

 Performance 
       Timeline  
Smartgiant Technology 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Smartgiant Technology Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Smartgiant Technology may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Cabio Biotech Wuhan 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Cabio Biotech Wuhan are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Cabio Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Smartgiant Technology and Cabio Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Smartgiant Technology and Cabio Biotech

The main advantage of trading using opposite Smartgiant Technology and Cabio Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smartgiant Technology position performs unexpectedly, Cabio Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cabio Biotech will offset losses from the drop in Cabio Biotech's long position.
The idea behind Smartgiant Technology Co and Cabio Biotech Wuhan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk